Medical Marijuana, Inc.’s HempMeds CBD Oil Products Featured by Yahoo Finance
The Big Trend in Medical Marijuana: Products that Don‘t Get you High – Yahoo Finance Reports from the International Cannabis Association‘s Historic New York Conference & Expo
SAN DIEGO, Oct. 21, 2014 (GLOBE NEWSWIRE) — Hundreds of attendees, speakers, exhibitors, lawmakers, and members of the news media from around the world converged on the International Cannabis Association‘s East Coast Regulatory Summit and Educational Conference in Times Square last week.
At the first and largest “pot-preneur” conference and expo to be hosted in New York, many budding entrepreneurs sought guidance from cannabis industry veterans in attendance. HempMeds(TM) — a Medical Marijuana, Inc. (OTC Pink:MJNA) portfolio company and the world’s most trusted supplier of natural cannabidiol (CBD) hemp oil products — was a sponsor and exhibitor gaining the attention of multiple media outlets including Yahoo! Finance in the report The Big Trend in Medical Marijuana: Products that Don‘t Get you High.
“We are very humbled and grateful to Yahoo! Finance for picking up on this major trend in the cannabis industry,” states Andrew Hard, Director of Public Relations for General Hemp and Spokesperson for HempMeds(TM). “When it comes to CBD oil from hemp, one simply cannot get ‘stoned’ or ‘high.’ As a result, consumers of CBD hemp oil from HempMeds(TM) range in age from toddlers to seniors. And cannabis is no longer limited to humans. We are extremely excited to have recently announced aNew Pet nutritional solutions for our four-legged family members.”
The global cannabis landscape is changing quickly. Once demonized in the U.S., decades of research has uncovered the truth about this ancient plant species that is fueling demand for cannabis products to be supplied to the global economy. Current CBD hemp oil products that are available in all 50 states and more than 40 countries range from nutritional supplements in tinctures, capsules, chewing gum and concentrated raw oil to luxury anti-aging beauty products that one would find at a department store cosmetics counter.
Hard continues, “The Company believes in ‘whole plant’ access. However, what we can provide to all regardless of whether one lives in a medical marijuana, CBD-only or a non-legalized state – today – is CBD hemp oil. We are very proud to announce that one does not need to move in order to access hemp CBD oil products. We encourage consumers to do their research on CBD from hemp and decide if this is a product to consider adding to their daily routines.”
Also reporting on natural CBD hemp oil at theInternational Cannabis Association were media outlets including Reuters, Reuters UK, Avax Newspictures, Fortune Magazine, and CNBC.
For more information on HempMeds(TM) and their all-natural CBD hemp oil products, visit:www.hempmeds.com. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds(TM) through the Company’s social media websites onFacebook and Twitter.
HempMeds(TM) offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds(TM) is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution,HempMeds(TM) is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact: Investor Relations contact: Perry Coleman Medical Marijuana, Inc. P. 443-453-5088 email@example.com Public Relations contact: Andrew Hard Director of PR, General Hemp P. 858-380-5478 firstname.lastname@example.org Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | email@example.com